ConductScience.org, home

Paper41978693

Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre.

Cuenco FM and 4 others. Rheumatol Adv Pract, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre. Papers, record 41978693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41978693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre.
PubMed
Journal
Rheumatol Adv Pract
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cuenco FMFrancis Martin
2Yamamoto SShintarohttps://orcid.org/0000-0002-6172-9116
3Yoshida AAkirahttps://orcid.org/0000-0003-3590-1637
4Gono TTakahisahttps://orcid.org/0000-0002-2593-1771
5Kuwana MMasatakahttps://orcid.org/0000-0001-8352-6136

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125448790Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study.J Rheumatol2015https://conductscience.org/library/papers/25448790PubMed
239320903Application of Risk-Based Cancer Screening in Patients With Dermatomyositis.JAMA Dermatol2024https://conductscience.org/library/papers/39320903PubMed
331444556Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.Rheumatol Int2019https://conductscience.org/library/papers/31444556PubMed
439798246Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies.Semin Arthritis Rheum2025https://conductscience.org/library/papers/39798246PubMed
5290795902017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.Ann Rheum Dis2017https://conductscience.org/library/papers/29079590PubMed
615273333Estimated radiation risks potentially associated with full-body CT screening.Radiology2004https://conductscience.org/library/papers/15273333PubMed
721987216Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.Arthritis Rheum2012https://conductscience.org/library/papers/21987216PubMed
839674189Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data.Lancet Oncol2025https://conductscience.org/library/papers/39674189PubMed
933919987Prevalence of Nasopharyngeal Carcinoma in Patients with Dermatomyositis: A Systematic Review and Meta-Analysis.Cancers (Basel)2021https://conductscience.org/library/papers/33919987PubMed
1031812369Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.Lancet Glob Health2020https://conductscience.org/library/papers/31812369PubMed
1139287015Validation of the International Myositis Assessment and Clinical Studies Group guideline on cancer risk stratification.Rheumatology (Oxford)2025https://conductscience.org/library/papers/39287015PubMed
1238769913Real-world implications of IMACS malignancy screening guidelines for idiopathic inflammatory myopathies: An evaluation of compliance and economic impact at a tertiary referral center.Int J Rheum Dis2024https://conductscience.org/library/papers/38769913PubMed
1325923553Inflammatory muscle diseases.N Engl J Med2015https://conductscience.org/library/papers/25923553PubMed
1440132728
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening recommendations detect most malignancies in patients with dermatomyositis: Retrospective performance in a tertiary-care center cohort.
J Am Acad Dermatol2025https://conductscience.org/library/papers/40132728PubMed
1537945774International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.Nat Rev Rheumatol2023https://conductscience.org/library/papers/37945774PubMed
1634278281Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns.EClinicalMedicine2021https://conductscience.org/library/papers/34278281PubMed
1730535395The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis.Rheumatology (Oxford)2019https://conductscience.org/library/papers/30535395PubMed
1835662349A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting.Mod Rheumatol2023https://conductscience.org/library/papers/35662349PubMed
1929529898Improved quantification of a commercial enzyme-linked immunosorbent assay kit for measuring anti-MDA5 antibody.Mod Rheumatol2019https://conductscience.org/library/papers/29529898PubMed
2027247435Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis.Rheumatology (Oxford)2016https://conductscience.org/library/papers/27247435PubMed

See all 28 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42259969Progress made and the road ahead for cancer screening in myositis.Nat Rev Rheumatol2026https://conductscience.org/library/papers/42259969

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41978693

GET https://conductscience.org/api/papers/v1/41978693/references?page=2